ArticleStem cell reviews and reports2025

Chidamide, Rituximab Plus EAC Regimen with Autologous Hemopoietic Stem Cell Transplantation in High-risk and Relapsed/Refractory B-cell Lymphoma and Long Term Follow-up.

Shunhua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.